Figure 2. Active ABL assembles the RUNX2-TAZ transcription factor complex required for osteoblast differentiation. (A) Primary murine osteoblasts were cultured in osteogenic medium for 14 days, and phosphotyrosine immune complexes were probed with an anti-ABL antibody. WCLs were probed with the indicated antibodies for Western blot analysis. (B) HEK293T cells were cotransfected with Flag-TAZ and RUNX2, with or without ABL (PP or KD). Flag-TAZ immune complexes were probed with an anti-RUNX2 antibody. (C) Luciferase activity from a BGLAP reporter assay in HEK293T cells cotransfected with the indicated constructs. n = 3. (D and E) HEK293T cells were cotransfected with the indicated constructs, and RUNX2 (D) or ABL (E) immune complexes were probed with an anti-ABL (D) or anti-Flag (E) antibody. (F) HEK293T cells infected with shGFP or shABL were cotransfected with RUNX2 and Flag-TAZ. The nuclear compartment was extracted from the cells, and Flag-TAZ immune complexes were probed with an anti-RUNX2 antibody. (G and H) HEK293T cells were cotransfected with WT or YF RUNX2 (G) or Flag-TAZ (H), with or without ABL (PP). RUNX2 (G) or Flag-TAZ (H) immune complexes were probed with an anti-p-Tyr antibody. (I) Primary murine osteoblasts infected with shGFP or shABL were cultured in osteogenic medium. p-Tyr or RUNX2 immune complexes were probed with an anti-RUNX2 or anti-TAZ antibody. (J) Luciferase activity from a Bglap reporter assay in primary murine osteoblasts in the presence of shGFP or shABL. n = 3. (K and L) Saos-2 cells infected with an empty vector control or an FKBP-ABL-expressing retroviral vector in the presence of shGFP (K and L), shRUNX2 (K), or shTAZ (L) were cultured in growth medium containing 50 nM FK1012. Cells were stained with alizarin red S solution. n = 3. *P < 0.05, by ANOVA with a Tukey-Kramer post-hoc test. Data represent the mean Ā± SEM. YAP has previously been reported to be stabilized following tyrosine phosphorylation by ABL (25). In distinction, we observed that all-tyrosine-to-phenylalanine-mutant TAZ (YF) was also stabilized by active ABL (PP) (Supplemental Figure 4F), suggesting that TAZ stabilization by ABL is not mediated by tyrosine phosphorylation. TAZ is degraded following the phosphorylation of Ser311 by LATS, which primes for the phosphorylation of Ser314 by CK1Īµ (26). Phosphorylated Ser314 lies in the TAZ phosphodegron and triggers binding to and subsequent ubiquitylation of TAZ by the E3-ubiquitin ligase Ī²-TrCP (26). We hypothesized that ABL suppressed TAZ ubiquitylation through disruption of the interaction between TAZ and Ī²-TrCP and observed that ABL (PP), but not ABL (KD), diminished the interaction between these proteins ( Figure 4F). These data demonstrate that ABL stabilizes TAZ through the suppression of its ubiquitin-mediated degradation pathway initiated by Ī²-TrCP.
The Journal of Clinical Investigation R E S E A R C H A R T I C L EABL stabilizes the TAZ-TEAD complex required for osteoblast expansion. We have shown that ABL mediated stabilization of TAZ protein and asked whet...